ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A BioLiving Periosteum Evokes Centripetal Regeneration in Challenging Bone Defects.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Large bone defects often exhibit compromised bone healing in the central region. Natural periosteum serves as a bioactive barrier by preventing unwanted fibroblast infiltration and providing regenerative cells. However, a significant gap remains in obtaining desirable central bone healing in large bone defects, and the challenge of achieving a balance between the dense barrier structure and bioactive functionality remains unresolved. Herein, a BioLiving periosteum is engineered to recapitulate key features of native periosteum. The middle mini-tissue is obtained by the liquid substrate culture (LSC) method, and encapsulated between a fiber-guiding layer and a recruitment layer, both of which feature topological structures. The LSC method endows endothelial cells (ECs) with an elevated glycolytic activity, facilitating their transition to a type-H phenotype, which could secrete multiple growth factors (chemical signals) to recruit endogenous cells. Subsequently, the recruited cells are further guided by the radial topological structure (physical signals) to migrate toward the central area. The combination of remote chemical cues and contact physical cues functions in a signaling-relay manner, effectively promoting bone formation in the central area of the defect. Thus, the BioLiving periosteum triggers centripetal bone regeneration through a physicochemical signaling-relay mode, representing a promising therapeutic strategy for severe bone defects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.